FLIP protein and TRAIL-induced apoptosis

Related Experiment Video

Updated: Aug 24, 2026

Analysis of Apoptosis in Zebrafish Embryos by Whole-mount Immunofluorescence to Detect Activated Caspase 3
08:20

Analysis of Apoptosis in Zebrafish Embryos by Whole-mount Immunofluorescence to Detect Activated Caspase 3

Published on: December 20, 2013

Wilfried Roth1, John C Reed

  • 1The Burnham Institute, La Jolla, California 92037, USA.

Vitamins and Hormones
|April 28, 2004
PubMed

Insights

Death ligands and receptors are key in immune responses and disease. Inhibiting FLIP protein could make cancer cells more sensitive to TRAIL-induced apoptosis, offering a potential anticancer therapy.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Death ligands (e.g., FasL, TRAIL) and death receptors (e.g., Fas, TRAIL-R1/DR4, TRAIL-R2/DR5) mediate apoptosis for immune regulation and elimination of infected or cancerous cells.
  • Dysregulation of these death receptor pathways is linked to autoimmune diseases, immunodeficiency, and cancer development.
  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) shows promise as an anticancer agent due to its selective tumor cell apoptosis induction.

Purpose of the Study:

  • To explore the role of death receptor-dependent apoptotic signaling in disease.
  • To investigate TRAIL as a potential anticancer therapeutic.
  • To evaluate the therapeutic potential of down-regulating FLICE-inhibitory protein (FLIP) to enhance TRAIL-induced apoptosis in cancer cells.

Main Methods:

  • Analysis of death ligand and receptor involvement in immune-mediated cell neutralization.
  • Investigation of the role of dysregulated apoptotic signaling in disease pathogenesis.
  • Examination of FLIP's mechanism in blocking TRAIL-mediated apoptosis.
  • Exploration of pharmacologic strategies to down-regulate FLIP.

Main Results:

  • Death receptor pathways are crucial for eliminating harmful cells but their dysregulation contributes to diseases.
  • TRAIL selectively induces apoptosis in tumor cells, making it a promising anticancer agent.
  • FLICE-inhibitory protein (FLIP) effectively inhibits TRAIL-induced apoptosis by blocking caspase-8 activation.

Conclusions:

  • Targeting death receptor pathways is critical for understanding and treating various diseases.
  • FLIP's inhibition of TRAIL-mediated apoptosis presents a therapeutic target.
  • Pharmacologic down-regulation of FLIP may sensitize tumor cells to TRAIL, enhancing its anticancer efficacy.

More Related Videos

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

In Vivo Biosensor Tracks Non-apoptotic Caspase Activity in Drosophila13:21

In Vivo Biosensor Tracks Non-apoptotic Caspase Activity in Drosophila

Published on: November 27, 2016

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.